Apollo and other PE firms are hungry for early-stage life sciences VCs

Apollo has announced it will buy a minority stake in Paris-based life sciences VC firm Sofinnova Partners, following Carlyle's purchase of Abingworth and EQT's acquisition of LSP.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.